IP Library › Patent Application 17749586
Patent Application
App. No. 17/749,586

COMPOSITION FOR RESPIRATORY DISEASES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/749,586
Abstract

A composition for the treatment and providing quick relief for respiratory diseases, such as Flu and Asthma. The composition includes Glutathione; Mentha oil; Pyrroloquinoline quinone; Wintergreen oil; and Eucalyptus oil. The composition is administered through the nasal route.

Claims (51)

1 . A composition for treatment and relief of respiratory diseases, the composition comprising:

Glutathione;

Mentha oil;

Pyrroloquinoline quinone;

Wintergreen oil; and

Eucalyptus oil.

2 . The composition according to claim 1 , wherein:

Glutathione is present in an amount ranging from 15-25%;

Mentha oil is present in an amount ranging from 15-25%;

Pyrroloquinoline quinone is present in an amount ranging from 10-20%;

Wintergreen oil is present in an amount ranging from 5-15%; and

Eucalyptus oil is present in an amount ranging from 5-15%.

3 . The composition according to claim 1 , wherein:

Glutathione is present in an amount of 45%;

Mentha oil is present in an amount of 20%;

Pyrroloquinoline quinone is present in an amount of 15%;

Wintergreen oil is present in an amount of 10%; and

Eucalyptus oil is present in an amount of 10%.

4 . A nasal dosage form for treatment and relief of respiratory diseases, the nasal dosage form comprises:

Glutathione;

Mentha oil;

Pyrroloquinoline quinone;

Wintergreen oil; and

Eucalyptus oil.

5 . The nasal dosage form according to claim 4 , wherein:

Glutathione is present in an amount ranging from 15-25%;

Mentha oil is present in an amount ranging from 15-25%;

Pyrroloquinoline quinone is present in an amount ranging from 10-20%;

Wintergreen oil is present in an amount ranging from 5-15%; and

Eucalyptus oil is present in an amount ranging from 5-15%.

6 . The nasal dosage form according to claim 4 , wherein:

Glutathione is present in an amount of 45%;

Mentha oil is present in an amount of 20%;

Pyrroloquinoline quinone is present in an amount of 15%;

Wintergreen oil is present in an amount of 10%; and

Eucalyptus oil is present in an amount of 10%.

7 . A method for treatment and providing relief in respiratory diseases, the method comprises the steps of:

providing a composition comprising Glutathione, Mentha oil, Pyrroloquinoline, quinone, Wintergreen oil, and Eucalyptus oil; and

administering the composition through a nasal route.

8 . The method according to claim 7 , wherein:

Glutathione is present in an amount ranging from 15-25%;

Mentha oil is present in an amount ranging from 15-25%;

Pyrroloquinoline quinone is present in an amount ranging from 10-20%;

Wintergreen oil is present in an amount ranging from 5-15%; and

Eucalyptus oil is present in an amount ranging from 5-15%.

9 . The method according to claim 7 , wherein:

Glutathione is present in an amount of 45%;

Mentha oil is present in an amount of 20%;

Pyrroloquinoline quinone is present in an amount of 15%;

Wintergreen oil is present in an amount of 10%; and

Eucalyptus oil is present in an amount of 10%.